AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Tectonic Therapeutic, Inc. Common Stock
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00DJ4T7F9
20.07▼ 1.02 (-4.84%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
21.09
Day's Range
19.83 – 22.31
52-Week Range
15.52 – 39.53
Volume
144.8K
Avg Volume
228.0K
Share Statistics
Shares Outstanding
Employees
60
Exchange
XNAS
Listed
2024-06-21
Share count as of July 31, 2026

Tectonic Therapeutic, Inc. Common Stock (TECX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Tectonic Therapeutic, Inc. Common Stock (TECX)
What is Tectonic Therapeutic, Inc. Common Stock's Market Cap?
Tectonic Therapeutic, Inc. Common Stock's Market Cap is $392.4M, based on as-reported figures from SEC (XBRL) filings.
What is Tectonic Therapeutic, Inc. Common Stock's Enterprise Value?
Tectonic Therapeutic, Inc. Common Stock's Enterprise Value is $165.5M, based on as-reported figures from SEC (XBRL) filings.
What is Tectonic Therapeutic, Inc. Common Stock's EV / EBITDA?
Tectonic Therapeutic, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Tectonic Therapeutic, Inc. Common Stock's Net Income (TTM)?
Tectonic Therapeutic, Inc. Common Stock's Net Income (TTM) is -$85.8M, based on as-reported figures from SEC (XBRL) filings.
What is Tectonic Therapeutic, Inc. Common Stock's EBITDA?
Tectonic Therapeutic, Inc. Common Stock's EBITDA is -$93.7M, based on as-reported figures from SEC (XBRL) filings.
What is Tectonic Therapeutic, Inc. Common Stock's Diluted EPS (TTM)?
Tectonic Therapeutic, Inc. Common Stock's Diluted EPS (TTM) is -4.39, based on as-reported figures from SEC (XBRL) filings.
What is Tectonic Therapeutic, Inc. Common Stock's Net Debt?
Tectonic Therapeutic, Inc. Common Stock's Net Debt is -$226.9M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · TECXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development—
General and administrative—
Total operating expenses—
Loss from operations—
Other income (expense):
Interest income—
Interest expense—
Change in fair value of SAFE liabilities——
Other expense—
Total other income, net—
Loss before income tax—
Income tax expense—
Net loss
Net loss per share, basic—
Net loss per share, diluted—